LONG-TERM PROGNOSIS IN PATIENTS WITH A LOCAL BREAST CANCER RELAPSE AFTER ORGAN-SAVING TREATMENT
https://doi.org/10.17650/1994-4098-2009-0-3-4-5-10
Abstract
The paper presents the results of a follow-up of 861 patients who have undergone organ-saving treatment (OST) for early breast can- cer. The relapse rate was 7.3% (63/861). The main task was to study an association of survival rates with the predictors characteriz- ing a local relapse. Five-year overall survival after the start of treatment for a local relapse was 65.7% (standard error 8.3). A Cox multivariance regression analysis led to the conclusion that the local relapse is a statistically significant factor of worsening survival without distant metastases when it develops within 3 years after primary OST.
About the Authors
V. A. Uimanov
Radiology Department, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
M. I. Nechushkin
Radiology Department, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
I. A. Gladilina
Radiology Department, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
A. V. Trigolosov
Radiology Department, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
N. R. Molodikova
Radiology Department, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
M. V. Chernykh
Radiology Department, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
References
1. Моисеенко В.М. «Естественная история» роста рака молочной железы. Практ Онкол 2002;3(1): 6—14.
2. Fisher В., Fisher E. Biologic aspects of cancer-cell spread. Proceedings of the Fifth National Cancer Conference. Philadelphia, Pennsylvania: Lippincott, 1965. p. 105—22.
3. Van Dongen J.A., Voogd A.C., Fentiman I.S. et al. Long-term results of a randomized trial comparing breast- conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000;92:1143—50.
4. Veronesi U., Cascinelli N., Mariani L. et al. Twenty-year follow-up of a ran- domized study comparing breast-con- serving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1217—32.
5. Krauss D.J., Kestin L.L., Mitchell C. et al. Changes in temporal patterns of local failure after breast-conserving ther- apy and their prognostic implications. Int J Radiat Oncol Biol Phys 2004;60: 731—40.
6. Calle R., Vilcoq J.R., Zafrani B. et al. Local control and survival of breast can- cer treated by limited surgery followed by irradiation. Int J Radiat Oncol Biol Phys 1986;(12):873—8.
7. Kurtz J.M., Amalric R., Brandone H. et al. Local recurrence after breast-con- serving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer 1989;63(10):1912—7.
8. Van Tienhoven G., Voogd A.C., Peterse J.L. et al. Prognosis after treat- ment for loco-regional recurrence after mastectomy or breast-conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer 1999;35(1): 32—8.
9. Fisher B., Anderson S., Fisher E.R. et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 1991;338(8763):327—31.
10. Rouzier R., Extra J.-M., Carton M. et al. Primary chemotherapy for operable breast cancer: Incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving sur- gery. J Clin Oncol 2001;19(18):3828—35.
11. Voogd A.C., van Oost F.J., Rutgers E.J. et al. Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer 2005:41(17):2637—2544.
12. Fredriksson I., Liljegren G., Arnesson L.G. et al. Local recurrence in the breast after conservative surgery — a study of prognosis and prognostic fac- tors in 391 women. Eur J Cancer 2002;(38):1860.
13. Le^ M.G., Arriagada R., Spielmann M. et al. Prognostic factors for death after an isolated local recur- rence in patients with early-stage breast carcinoma. Cancer 2002;94(11): 2813—20.
14. Huang E., Buchholz T.A., Meric F. et al. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer 2002;95(10):2059—67.
15. Smith T.E., Lee D., Turner B. et al. True recurrence vs. new primary ipsilater- al breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 2000;48:1281—9.
16. Fortin A., Larochelle M., Laverdiere J. et al. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol 1999;17(1):101—9.
17. Gage I., Schnitt S.J., Recht A. et al. Skin recurrences after breast-conserving therapy for early-stage breast cancer. J Clin Oncol 1998;16(2):480—6.
18. Нечушкин М.И. Лечение больных раком молочной железы центральной и медиальной локализации с использованием радиохирургических методик. Дис. ... докт. мед. наук. М., 2001.
Review
For citations:
Uimanov V.A., Nechushkin M.I., Gladilina I.A., Trigolosov A.V., Molodikova N.R., Chernykh M.V. LONG-TERM PROGNOSIS IN PATIENTS WITH A LOCAL BREAST CANCER RELAPSE AFTER ORGAN-SAVING TREATMENT. Tumors of female reproductive system. 2009;(3-4):5-10. (In Russ.) https://doi.org/10.17650/1994-4098-2009-0-3-4-5-10
Views:
589
Email this article 